Small molecule GLP-RAs hold a potential to transform the landscape of metabolic and chronic disease management
This approach is especially valuable as we continue to refine diagnostic criteria for clinical obesity
12-14 In phase III clinical studies in which exenatide was administered concomitantly with metformin, an SU, or metformin plus an SU, 48% of the 483 patients receiving exenatide 10 mcg twice daily reported nausea compared to 18% of the 483 patients receiving placebo
And this is where it helps to expand what we mean by progress, because it doesnt always look dramatic In social media, fitness, culture, progress is often portrayed as huge jumps in weight lifted or dramatic physical transformations
Here are things to do to support GLP-1: Exercise GLP-1 levels have been shown to increase after moderate exercise, helping with appetite control and post-meal satiety
Warnings: Allergy alert: Do not use if you have ever had a rash or other allergic reaction to Loperamide HCl
